Decreased cardiovagal regulation in exfoliation syndrome

Journal of Glaucoma

Volumn 17, Issue 2, 2008, Pages 133-138

  Visontai, Zsuzsanna ^a   Horváth, Tamás ^a   Kollai, Márk ^a   Holló, Gábor ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NONE   (Hungary)

Author keywords

Baroreflex sensitivity; Exfoliation syndrome; Heart rate variability; Pulse wave velocity

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRIC OXIDE DONOR;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; EXFOLIATION SYNDROME; FEMALE; GROUPS BY AGE; HEART RATE VARIABILITY; HUMAN; MALE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PULSE WAVE; SEX DIFFERENCE; SYSTEMIC DISEASE;

ADULT; AGED; AGED, 80 AND OVER; BAROREFLEX; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; EXFOLIATION SYNDROME; FEMALE; GLAUCOMA, OPEN-ANGLE; HEART RATE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; TONOMETRY, OCULAR; VAGUS NERVE;

EID: 40949118929     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e3181379d67     Document Type: Article

References (36)

1. Streeten BW, Gibson SA, Dark AJ. Pseudoexfoliative material contains an elastic microfibrillar-associated glycoprotein. Trans Am Ophthalmol Soc. 1986;84:304-320.
2. Zenkel M, Pöschl E, von der Mark K, et al. Differential gene expression in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci. 2005;46:3742-3752.
3. Schlötzer-Schrehardt U, Koca MR, Naumann GOH, et al. Pseudoexfoliation syndrome ocular manifestation of a systemic disorder? Arch Ophthalmol. 1992;110:1752-1756.
4. Streeten BW, Zong-Yi L, Wallace RN, et al. Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol. 1992;110:1757-1762.
5. Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45:265-315.
6. Konstas AGP, Holló G, Astakhov YS, et al. Factors associated with long-term progression or stability in exfoliation glaucoma. Arch Ophthalmol. 2004;122:29-33.
7. Naumann GOH, Schlötzer-Schrehardt U, Küchle M. Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Ophthalmology. 1998;105:951-968.
8. Asano N, Schlötzer-Schrehardt U, Naumann GOH. A histopathologic study of iris changes in pseudoexfoliation syndrome. Ophthalmology. 1995;102:1279-1290.
9. Repo LP, Teräsvirta ME, Koivisto KJ. Generalized transluminance of the iris and the frequency of the pseudoexfoliation syndrome in the eyes of transient ischemic attack patients. Ophthalmology. 1993;100:352-355.
10. Parodi MB, Bondel E, Saviano S, et al. Iris indocyanine green angiography in pseudoexfoliation syndrome and capsular glaucoma. Acta Ophthalmol Scand. 2000;78:437-442.
11. Helbig H, Schlötzer-Schrehardt U, Noske W, et al. Anterior-chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome. German J Ophthalmol. 1994;3:148-153.
12. Vessani RM, Ritch R, Liebmann JM, et al. Plasma homocysteine is elevated in patients with exfoliation syndrome. Am J Ophthalmol. 2003;136:41-46.
13. Leibovitch I, Kurtz S, Shemesh G, et al. Hyperhomocysteinemia in pseudoexfoliation glaucoma. J Glaucoma. 2003;12:36-39.
14. Puustjärvi T, Blomster H, Kontkanen M, et al. Plasma and aqueous humour levels of homocysteine in exfoliation syndrome. Graefe's Arch Clin Exp Ophthalmol. 2004;242:749-754.
15. Altintas Ö, Maral H, Yüksel N, et al. Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma. Graefe's Arch Clin Exp Ophthalmol. 2005;243:677-683.
16. Taute BM, Taute R, Heins S, et al. Hyperhomocysteinemia: marker of systemic atherosclerosis in peripheral arterial disease. Int Angiol. 2004;23:35-40.
17. Durga J, Verhoef P, Bots ML, et al. Homocysteine and carotid intima-media thickness: a critical appraisal of the evidence. Atherosclerosis. 2004;176:1-19.
18. Bortolotto LA, Safar ME, Billaud E, et al. Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. Hypertension. 1999;34:837-842.
19. Holló G, Józsa G, Kempler P, et al. Altered regulation of systemic circulation in capsular glaucoma. Ophthalmol Hungarica. 1998;135:51-54.
20. Holló G, Lakatos P, Farkas K. Cold pressor test and plasma endothelin-1 concentration in primary open-angle and capsular glaucoma. J Glaucoma. 1998;7:105-110.
21. Visontai ZS, Mersich B, Kollai M, et al. Increase of carotid artery stiffness and decrease of baroreflex sensitivity in exfoliation syndrome and glaucoma. Br J Ophthalmol. 2006;90:563-567.
22. Bojic L, Ermacora R, Polic S, et al. Pseudoexfoliation syndrome and asymptomatic myocardial dysfunction. Graefe's Arch Clin Exp Ophthalmol. 2005;243:446-449.
23. Mitchell P, Wang JJ, Smith W. Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol. 1997;124:685-687.
24. Ritland JS, Egge K, Lydersen S, et al. Exfoliative glaucoma and primary open-angle glaucoma: associations with death causes and comorbidity. Acta Ophthalmol Scand. 2004;82:401-404.
25. Konstas AGP, Tsatsos I, Kardasopoulos A, et al. Preoperative features of patients with exfoliation glaucoma and primary open-angle glaucoma. The AHEPA study. Acta Ophthalmol Scand. 1998;76:208-212.
26. Ringvold A, Blika S, Sandvik L. Pseudo-exfoliation and mortality. Acta Ophthalmol Scand. 1997;75:255-256.
27. Shrum KR, Hattenhauer MG, Hodge D. Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol. 2000;129:83-86.
28. Grødum K, Heijl A, Bengtsson B. Glaucoma and mortality. Graefe's Arch Clin Exp Ophthalmol. 2004;242:397-401.
29. Schumacher S, Schlötzer-Schrehardt U, Martus P, et al. Pseudoexfoliation syndrome and aneurysms of the abdominal aorta. Lancet. 2001;357:359-360.
30. Hietanen J, Soisalon-Soininen S, Kivelä T, et al. Evaluation of the clinical association between exfoliation syndrome and abdominal aortic aneurysm. Acta Ophthalmol Scand. 2002;80:617-619.
31. Task Force of European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93:1043-1065.
32. Konstas AGP, Holló G, Astakhov YS, et al. Presentation and long-term follow-up of exfoliation glaucoma in Greece, Spain, Russia and Hungary. Eur J Ophthalmol. 2006;16:60-66.
33. Bigger JT Jr, Fleiss JL, Rolnitzky LM, et al. Myocardial infarction: the ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation. 1993;88:927-934.
34. Dekker JM, Crow RS, Folsom AR, et al. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes. The ARIC study. Circulation. 2000;102:1239-1244.
35. Citirik M, Acaroglu G, Batman C, et al. A possible link between the pseudoexfoliation syndrome and coronary artery disease. Eye. 2007;21:11-15.
36. Riccadonna M, Covi G, Pancera P, et al. Autonomic systemic activity and 24-hour blood pressure variations in subjects with normal- and high-tension glaucoma. J Glaucoma. 2003;12:156-163.